Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Metabolix, Inc

Since our founding in 1992, our interdisciplinary team has worked to apply the cutting edge tools of biotechnology to create a new family of natural plastics, and has succeeded in transforming the biological production of these materials from laboratory curiosity to commercial reality. We have truly progressed far along the way to realizing our Vision of a sustainable future through biotechnology for natural plastics, fuels, and energy. Sustainability has been eloquently defined by the World Commission on Environment and Development as "development that meets the needs of the present world without compromising the ability of future generations to meet their own needs." It represents an enormous challenge for a world that's placing ever greater demands on the earth that supports us.
Metabolix is meeting this challenge by harnessing the solar collecting ability so highly evolved in green plants to produce materials that will replace many of those now made from petroleum and natural gas. It is an exciting effort which has had the support of the U.S. Department of Energy, the U.S. Department of Agriculture, and the U.S. Department of Commerce’s NIST ATP program. In 2004, we formed a strategic alliance with Archer Daniels Midland, one of the world’s leading agricultural products processors and industrial scale fermentors, that will create a joint venture to commercialize Metabolix’s natural plastics made via fermentation – the conversion of sugars and vegetable oils using microbial biofactories.


Contact Details:
21 Erie Street
Cambridge
Massachusetts
02139-4260
United States of America
Tel:617 492 0505
Fax:617 492 1996
Email:webmaster@linkwell.com
WWW:

www.metabolix.com/




Loading...

BioNews Results for Metabolix, Inc:

Metabolix Announces Completion of Common Stock Offering
RBC Dain Rauscher:  Nov 16 2009 4:32PM Matching: metabolix inc
Metabolix, Inc. Prices Common Stock Offering
BioSpace:  Nov 11 2009 3:43PM Matching: metabolix inc
Metabolix, Inc. Announces Commencement of Public Offering of Common Stock
BioSpace:  Nov 11 2009 7:44PM Matching: metabolix inc
Metabolix Prices Common Stock Offering
NewsBlaze:  Nov 11 2009 7:01PM Matching: metabolix inc
Metabolix Prices Common Stock Offering
Yahoo! Canada:  Nov 11 2009 8:47PM Matching: metabolix inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Metabolix, Inc news.

Metabolix, Inc Patents:

US Patent No.Title
6323010 Polyhydroxyalkanoate biopolymer compositions
6620869 PHA compositions and methods for their use in the production of PHA films
6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
6623749 Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin
6689589 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids

View more Metabolix, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 324 times since April 2007, the link to the organisation's website has been followed 53 times

Search for more companies in Cambridge

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Metabolix, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.